The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
The Risk of Second Primary Malignancies up to Three Decades after the Treatment of Differentiated Thyroid Cancer
Abstract
Background: The 10-yr survival rate of patients with differentiated thyroid cancer exceeds 90%. These patients may be at elevated risk for secondary cancers. Methods: The risk of nonthyroid second primary malignancies after differentiated thyroid cancer was determined in 30,278 patients diagnosed between 1973 and 2002 from centers participating in the National Cancer Institute’s Surveillance, Epidemiology, and End Results program. Median follow-up was 103 months (range, 2–359 months). Risk was further assessed for the addition of radioisotope therapy, gender, latency to development of secondary cancer, and age at thyroid cancer diagnosis. Results: There were 2158 patients who developed a total of 2338 nonthyroid second primary malignancies, significantly more than that expected in the general population [observed/expected (O/E) = 1.09; 95% confidence interval (CI), 1.05–1.14; P < 0.05; absolute excess risk per 10,000 person-years (AER) = 6.39]. A significantly greater risk of second primary malignancies over that expected in the general population was for patients treated with radioisotopes (O/E = 1.20; 95% CI, 1.07–1.33; AER = 11.8) as well as for unirradiated patients (O/E = 1.05; 95% CI, 1.00–1.10; AER = 3.53). However, the increased risk was greater for the irradiated vs. the unirradiated cohort (relative risk = 1.16; 95% CI, 1.05–1.27; P < 0.05). Gender did not affect risk. The greatest risk of second primary cancers occurred within 5 yr of diagnosis and was elevated for younger patients. Conclusions: The overall risk of second primary malignancies is increased for thyroid cancer survivors and varies by radioisotope therapy, latency, and age at diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Papillary and Follicular Thyroid Carcinoma
Schlumberger, M. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380506 · Cited by 1,623
Thyroid Cancer after Exposure to External Radiation: A Pooled Analysis of Seven Studies
Ron, E., Lubin, J. H., Shore, R. E., Mabuchi, K., Modan, B., Pottern, L. M., Schneider, A. B., Tucker, M. A., & Boice, J. D. (2012) · Radiation Research · doi:10.1667/rrav05.1 · Cited by 1,124
Thyroid Cancer after Exposure to External Radiation: A Pooled Analysis of Seven Studies
Ron, E., Lubin, J. H., Shore, R. E., Mabuchi, K., Modan, B., Pottern, L. M., Schneider, A. B., Tucker, M. A., & Boice, J. D. (1995) · Radiation Research · doi:10.2307/3579003 · Cited by 1,107
Gilliland, F. D., Hunt, W. C., Morris, D. M., & Key, C. R. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970201)79:3<564::aid-cncr20>3.0.co;2-0 · Cited by 803
Second primary malignancies in thyroid cancer patients
Rubino, C., de Vathaire, F., Dottorini, M. E., Hall, P., Schvartz, C., Couette, J. E., Dondon, M. G., Abbas, M. T., Langlois, C., & Schlumberger, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601319 · Cited by 655
Multiplicative Models and Cohort Analysis
Breslow, N. E., Lubin, J. H., Marek, P., & Langholz, B. (1983) · Journal of the American Statistical Association · doi:10.1080/01621459.1983.10477915 · Cited by 565
CHEK2 Is a Multiorgan Cancer Susceptibility Gene
Cybulski, C., Górski, B., Huzarski, T., Masojć, B., Mierzejewski, M., Dębniak, T., Teodorczyk, U., Byrski, T., Gronwald, J., Matyjasik, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/426403 · Cited by 551
The incidence of secondary leukemias.
Leone, G. G. M., Mele, L., Pulsoni, A., Equitani, F., & Pagano, L. (1999) · PubMed · Cited by 346
Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure.
Levine, E. G., & Bloomfield, C. D. (1992) · PubMed · Cited by 332
The RET proto-oncogene in human cancers
Jhiang, S. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203857 · Cited by 298
Do Adults Change Their Lifestyle Behaviors After a Cancer Diagnosis?
Blanchard, C. M., Denniston, M. M., Baker, F., Ainsworth, S. R., Courneya, K. S., Hann, D. M., Gesme, D. H., Reding, D., Flynn, T., & Kennedy, J. S. (2003) · American Journal of Health Behavior · doi:10.5993/ajhb.27.3.6 · Cited by 278
The long-term hazards of the treatment of thyroid cancer with radioiodine
Edmonds, C. J., & Smith, T. (1986) · The British Journal of Radiology · doi:10.1259/0007-1285-59-697-45 · Cited by 246
The sodium iodide symporter: its pathophysiological and therapeutic implications
Spitzweg, C., & Morris, J. C. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01640.x · Cited by 200
The cancer epidemiology of radiation
Wakeford, R. (2004) · Oncogene · doi:10.1038/sj.onc.1207896 · Cited by 200
Second Primary Cancers in Thyroid Cancer Patients: A Multinational Record Linkage Study
Sandeep, T. C., Strachan, M. W. J., Reynolds, R. M., Brewster, D. H., Scélo, G., Pukkala, E., Hemminki, K., Anderson, A., Tracey, E., Friis, S., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2009 · Cited by 190
Thyroid cancer and multiple primary tumors in the SEER cancer registries1
Ronckers, C. M., McCarron, P., & Ron, E. (2005) · International Journal of Cancer · doi:10.1002/ijc.21064 · Cited by 153
The development of breast carcinoma in women with thyroid carcinoma
Chen, A. Y., Levy, L. B., Goepfert, H., Brown, B. W., Spitz, M. R., & Vassilopoulou‐Sellin, R. (2001) · Cancer · Cited by 125
Cybulski, C., Wokołorczyk, D., Huzarski, T., Byrski, T., Gronwald, J., Górski, B., Dębniak, T., Masojć, B., Jakubowska, A., Gliniewicz, B., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.044974 · Cited by 115
A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland
Cybulski, C., Wokołorczyk, D., Huzarski, T., Byrski, T., Gronwald, J., Górski, B., Dębniak, T., Masojć, B., Jakubowska, A., van de Wetering, T., et al. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9320-y · Cited by 113
Cancer risks in thyroid cancer patients
Hall, P. N., Holm, L.-E., Lundell, G. E. F., Bjelkengren, G., Larsson, L., Lindberg, S., Tennvall, J., Wicklund, H., & Boice, J. D. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.261 · Cited by 105
Verkooijen, R. B. T., Smit, J. W. A., Romijn, J. A., & Stokkel, M. P. M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02300 · Cited by 100
Risk of Second Primary Malignancies in Women with Papillary Thyroid Cancer
Canchola, A. J., Horn‐Ross, P. L., & Purdie, D. M. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj072 · Cited by 80
Thyroid Cancer Clinical Practice Guidelines in Oncology
Sherman, S. I., Angelos, P., Ball, D. W., Beenken, S. W., Byrd, D. R., Clark, O. H., Daniels, G. H., Dilawari, R. A., Ehya, H., Farrar, W. B., et al. (2005) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2005.0021 · Cited by 69
Epidemiology of Thyroid Cancer
Figge, J. J. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-995-0_2 · Cited by 67
Molecular Events in Follicular Thyroid Tumors
Kroll, T. G. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-8107-3_4 · Cited by 50
Iodine-131 in breast milk following therapy for thyroid carcinoma.
Robinson, P., Barker, P., Campbell, A. M., Henson, P. M., Surveyor, I., & Young, P. R. (1994) · PubMed · Cited by 43
Radiation induced thyroid neoplasms 1920 to 1987: A vanishing problem?
Mehta, M. P., Goetowski, P. G., & Kinsella, T. J. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90951-6 · Cited by 39
Second primary neoplasms after 19281 endocrine gland tumours
Hemminki, K., & Jiang, Y. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00175-7 · Cited by 35
Acute leukemias after treatment with radioiodine for thyroid cancer.
Schilling, V. R., Abellán, P. F., Escribano, J. R. D., Rivas González, C., Mut Barberá, E., & Calatayud Cendra, R. (1998) · PubMed · Cited by 30
Líška, J., Altanerova, V., Galbavý, Š., Stvrtina, S., & Brtko, J. (2005) · PubMed · Cited by 26
Cited by
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
“There appears to be an increased risk of breast cancer in women with thyroid cancer (281,399,404).”
InfluentialFrancis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Lin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082
Ringel, M. D., Sosa, J. A., Baloch, Z., Bischoff, L., Bloom, G., Brent, G. A., Brock, P. L., Chou, R., Flavell, R. R., Goldner, W., et al. (2025) · Thyroid® · doi:10.1177/10507256251363120 · Cited by 710
Metadata
- Authors
- Brown, A. P., Chen, J., Hitchcock, Y. J., Szabo, A., Shrieve, D. C., & Tward, J. D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-02-01
- Volume
- 93
- Issue
- 2
- Pages
- 504-515
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2167719032
- Cited by
- 384
- References
- 31
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.